Literature DB >> 1336065

Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure.

P J Gengo1, H N Sabbah, R P Steffen, J K Sharpe, T Kono, P D Stein, S Goldstein.   

Abstract

Effects of chronic heart failure upon receptor binding and cardiac function were studied in mongrel dogs. Heart failure was induced by three to seven, graded, sequential, intracoronary microembolizations performed 1 to 3 weeks apart. Depressed systolic and diastolic left ventricular function, reduced cardiac output, increased systemic vascular resistance, increased plasma norepinephrine concentration, left ventricular hypertrophy, and dilation were associated with the development of heart failure in this model. Three months after the last embolization, the density and affinity of myocardial beta adrenoceptors and voltage sensitive calcium channels were quantified by analyzing saturation isotherms of specific radioligand binding. [3H]Dihydroalprenolol and [3H]nitrendipine bound specifically and with high affinity to cardiac beta adrenoceptors and calcium channels, respectively. Scatchard transformation of the specific binding of these radioligands in membranes prepared following intracoronary embolization demonstrated a 47% decrease in the density of [3H]dihydroalprenolol binding sites (605 +/- 20 fmol/mg, normal, vs. 323 +/- 18 fmol/mg, failed; P < 0.05) and a 20% decrease in [3H]nitredipine binding sites (371 +/- 11 fmol/mg, normal, vs. 298 +/- 17 fmol/mg, failed; P < 0.05). The binding equilibrium dissociation constants for [3H]dihydroalprenolol and [3H]nitrendipine were not significantly different between normal and failed myocardium. There was no difference in the sialic acid content in the sarcolemmal membranes prepared from normal and failed dog hearts (31.07 +/- 0.76 nmol/mg, normal, vs. 30.58 +/- 5.25 nmol/mg, failed). This is inconsistent with the selective purification of membranes utilized in these radioligand binding studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336065     DOI: 10.1016/0022-2828(92)93100-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  10 in total

1.  Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure.

Authors:  Stephen Zicha; Victor A Maltsev; Stanley Nattel; Hani N Sabbah; Albertas I Undrovinas
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

2.  Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state.

Authors:  Atta U Shahbaz; Tieqiang Zhao; Wenyuan Zhao; Patti L Johnson; Robert A Ahokas; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Calcium channels and cation transport ATPases in cardiac hypertrophy induced by aortic constriction in newborn rats.

Authors:  L Zheng; M Wibo; F Kolár; T Godfraind
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms.

Authors:  Antonis A Armoundas; Jochen Rose; Rajesh Aggarwal; Bruno D Stuyvers; Brian O'rourke; David A Kass; Eduardo Marbán; Stephen R Shorofsky; Gordon F Tomaselli; C William Balke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-11-22       Impact factor: 4.733

Review 5.  Modeling heart failure in animal models for novel drug discovery and development.

Authors:  Paul M L Janssen; Mohammad T Elnakish
Journal:  Expert Opin Drug Discov       Date:  2019-03-12       Impact factor: 6.098

6.  Genome-wide approach to identify novel candidate genes for beta blocker response in heart failure using an experimental model.

Authors:  David E Lanfear; James J Yang; Sudhish Mishra; Hani N Sabbah
Journal:  Discov Med       Date:  2011-04       Impact factor: 2.970

7.  Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.

Authors:  Sharad Rastogi; Victor G Sharov; Sudhish Mishra; Ramesh C Gupta; Brent Blackburn; Luiz Belardinelli; William C Stanley; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-26       Impact factor: 4.733

8.  Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.

Authors:  George Suzuki; Takayuki Mishima; Elaine J Tanhehco; Victor G Sharov; Anastassia Todor; Sharad Rostogi; Ramesh C Gupta; Pervaiz A Chaudhry; Petros V Anagnostopoulos; Omar Nass; Sidney Goldstein; Hani N Sabbah
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure.

Authors:  Yan Guo; Cui Zhang; Tianxin Ye; Xiuhuan Chen; Xin Liu; Xiaoli Chen; Yazhou Sun; Chuan Qu; Jinjun Liang; Shaobo Shi; Bo Yang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.